---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-084529"
form_type: "8-K"
ticker: "MGX"
cik: "0001785279"
company_name: "Metagenomi Therapeutics, Inc."
filed_at: "2025-06-11T23:59:59+00:00"
generated_at: "2026-05-19T13:41:23.543049+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Metagenomi stockholders elect Dr. Willard H. Dere as Class I Director and ratify PwC as auditor

## Summary
- Dr. Willard H. Dere elected with 7,580,903 votes for, 2,891,893 withheld, and 8,292,425 broker non-votes.
- Ratification of PricewaterhouseCoopers LLP as independent auditor for FY2025: 17,970,776 for, 252,634 against, 541,811 abstentions.
- Annual meeting held June 10, 2025; quorum established with 18,765,221 shares present (50.2% of outstanding).

## SEC filing metadata
- accession: 0000950170-25-084529
- form_type: 8-K
- ticker: MGX
- cik: 0001785279
- company_name: Metagenomi Therapeutics, Inc.
- filed_at: 2025-06-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1785279/000095017025084529/0000950170-25-084529-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1785279/000095017025084529/mgx-20250610.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-084529
- JSON: https://secwatch.observer/filing/0000950170-25-084529.json
- Plain text: https://secwatch.observer/filing/0000950170-25-084529.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.